Homepage > Nachrichten > Text

Average reduction of 83.13%! The results of the centralized procurement of consumables of the 31 provinces mega alliance released

2023-06-12

On June 8, 2023, the Beijing-Tianjin-Hebei Medical Joint Procurement Platform released the “Beijing-Tianjin-Hebei” 3+N “Alliance joint bone cement medical consumables centralized Procurement of selected results” (hereinafter referred to as “Publicity”).

The procurement of 31 provinces (autonomous regions, municipalities directly under the Central Government) and Xinjiang Production and Construction Corps, a total of 4,762 medical institutions participated in the agreement to purchase about 640,000 basic packages, accounting for 95% of the total demand for joint bone cement in the alliance area, involving a market size of about 1.021 billion yuan.

   01

All the declared enterprises were selected, with an average decrease of 83.13%!

The results of the proposed selection show that all the 8 enterprises have obtained the qualification of the proposed selection. The lowest proposed selected price was 150 yuan/basic package, and the highest proposed selected price was 200 yuan/basic package

 

The product of joint bone cement corresponding to 20g powder was counted as a “base package”.

 

Previously, the lowest price of spinal bone cement was 21.68 yuan/gram, and the lowest price of joint bone cement was 7.5 yuan/gram, and the price difference was nearly 3 times!

From the point of view of the price reduction, the spine cement price announced by the spine centralized procurement was 66.58%, and the average price reduction of the centralized procurement was 83.13%, according to the agreed purchase volume, it is expected that the annual related costs will be reduced by 853 million yuan.

According to the notice, the Beijing-Tianjin-Hebei “3+N” alliance joint bone cement medical consumables centralized procurement cycle is 2 years, calculated from the actual implementation date of the results of the selection in various regions of the alliance, and the specific implementation date is determined by the regions of the alliance.

02

Under the background of centralized procurement, the price system of orthopedic consumables is about to be subverted!

The field of orthopedic consumables has gone through joint and spine centralized procurement, as well as trauma alliance centralized procurement, with an average decrease of over 80% in the selected products, the price system has changed, and the last kilometer of orthopaedic price reduction is about to be opened.

 In the national centralized procurement of joint, the average price of the selected hip decreased from 35,000 yuan to about 7,000 yuan, and the average price of the knee decreased from 32,000 yuan to about 5,000 yuan, an average decrease of 82%; The average price reduction of national centralized procurement of spine was  84%, and it is expected to save 26 billion yuan per year according to the agreed purchase volume.

For thoracic and lumbar posterior fixation fusion, which accounts for 1/3 of spinal operations, the average price of consumables per set dropped from 33,000 yuan to about 4,500 yuan.

This year, Sports medicine will also usher in national centralized procurement.

The deputy director of the National Healthcare Security Administration clearly pointed out at a press conference held in May that at the national level, the fourth batch of centralized procurement in high-value medical consumables will be carried out, mainly for ophthalmic intraocular lenses and orthopaedic sports medicine consumables.

The ophthalmic and orthopaedic medical consumables historical procurement data filling work organized by the state has been carried out in March.

Among them, orthopedic medical consumables include rivet,repair stitches,interfacial pin,cross stud,cartilage fixation nailsoft tissue fixation nailadjustable fixing platenon-adjustable fixing plateartificial ligament systemmeniscus repair and transplantation systemarthroscope matching systempulse washerdrill,grinding headplaner toolheterogeneous boneallograft bonesynthetic bone and bone forming protein, etc.

China is encouraging China end uses for more domestic products in latest years. Thus, more and more overseas manufacturers are planning localization in China. BradyKnows localization team has extensive experiences in facility establishment, audit, supplier evaluation, manufacturing, registration, and marketing in China. Pls feel free to let us know any questions on China entry via info@bradyknowsmedical.com

Article source:Device Market,Saibolan Device

Translated & edited : Bradyknows